New Mexico Educational Retirement Board bought a new stake in Steris PLC (NYSE:STE) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 21,017 shares of the medical equipment provider’s stock, valued at approximately $1,838,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Fisher Asset Management LLC raised its stake in shares of Steris by 3.0% in the third quarter. Fisher Asset Management LLC now owns 1,539,157 shares of the medical equipment provider’s stock valued at $136,061,000 after purchasing an additional 45,191 shares in the last quarter. Bessemer Group Inc. raised its stake in shares of Steris by 3.4% in the third quarter. Bessemer Group Inc. now owns 1,387,199 shares of the medical equipment provider’s stock valued at $122,630,000 after purchasing an additional 45,198 shares in the last quarter. American Century Companies Inc. raised its stake in shares of Steris by 14.6% in the fourth quarter. American Century Companies Inc. now owns 1,194,167 shares of the medical equipment provider’s stock valued at $104,454,000 after purchasing an additional 152,346 shares in the last quarter. Bank of New York Mellon Corp raised its stake in Steris by 4.9% during the third quarter. Bank of New York Mellon Corp now owns 1,017,810 shares of the medical equipment provider’s stock worth $89,974,000 after acquiring an additional 47,682 shares in the last quarter. Finally, Macquarie Group Ltd. raised its stake in Steris by 7.0% during the third quarter. Macquarie Group Ltd. now owns 885,960 shares of the medical equipment provider’s stock worth $78,318,000 after acquiring an additional 57,700 shares in the last quarter. Institutional investors and hedge funds own 89.47% of the company’s stock.
Several research analysts have issued reports on the company. KeyCorp reiterated a “buy” rating and set a $103.00 price objective on shares of Steris in a research note on Thursday, February 8th. Northcoast Research set a $102.00 price objective on Steris and gave the stock a “buy” rating in a research note on Thursday, February 8th. Zacks Investment Research lowered Steris from a “buy” rating to a “hold” rating in a research note on Wednesday, January 24th. Raymond James Financial reiterated a “market perform” rating and set a $100.00 price objective on shares of Steris in a research note on Wednesday, January 3rd. Finally, TD Securities increased their price objective on Steris from C$14.00 to C$16.00 and gave the stock a “buy” rating in a research note on Thursday, November 9th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $84.80.
Shares of Steris PLC (STE) opened at $90.11 on Monday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.22 and a current ratio of 2.82. The company has a market capitalization of $7,680.00, a price-to-earnings ratio of 31.73 and a beta of 1.22. Steris PLC has a 1-year low of $67.55 and a 1-year high of $93.71.
Steris (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.05. The business had revenue of $661.90 million for the quarter, compared to analysts’ expectations of $663.17 million. Steris had a return on equity of 11.57% and a net margin of 9.42%. The firm’s quarterly revenue was up 2.3% compared to the same quarter last year. During the same quarter last year, the business earned $0.98 earnings per share. research analysts expect that Steris PLC will post 4.13 EPS for the current fiscal year.
WARNING: This report was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.chaffeybreeze.com/2018/02/19/new-mexico-educational-retirement-board-invests-1-84-million-in-steris-plc-ste.html.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.